Found 11 matching trials
Safety and Efficacy of Percutaneous Coronary Intervention Combined With Thrombolysis at Different Time
NAPatients with acute ST-segment elevation myocardial infarction and thrombol...
Location
The second hospital of Jilin university
Pro-urokinase for Extended-Window Posterior Circulation Stroke
PHASE3This study aims to evaluate whether, in patients with imaging-confirmed acu...
Location
Department of Neurology, the First Affiliated Hospital of Zhengzhou University
Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
PHASE3This is a randomized, rt-PA controlled, open-label phase 3 clinical study t...
Location
Beijing Luhe Hospital,Capital Medical University
ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
PHASE3The purpose of this study is to investigate the safety and efficacy of rhPr...
Location
Taihe Hospital of Traditional Chinese Medicine
Intravenous rhPro-UK Before Stroke Thrombectomy in the Extended Time Window (BRIDGE-PUK EXTEND)
PHASE3This randomized, double-blind, placebo-controlled phase III clinical trial ...
Location
The First Hospital of Lanzhou University
Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke
PHASE3The HOPE-MeVO study aims to evaluate the efficacy and safety of intravenous...
Location
The First Affiliated Hospital of Anhui Medical University
Effects of Intracoronary Prourokinase on the Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction
PHASE4The purpose of this study is to determine whether intracoronary selective t...
Location
Department of Cardiology, Zhongshan Hospital, Fudan University
A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism
PHASE2This trial is being conducted to assess the efficacy and safety of recombin...
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
PHASE3This is a randomized,controlled, double-blinded, phase 3 clinical study to ...
Location
XuanWu Hospital, Capital Medical University
Real-World Evaluation of Recombinant Human Prourokinase for Acute Ischemic Stroke Within 4.5 Hours
N/AAcute ischemic stroke is a major cause of disability and death. Intravenous...
Location
The First Affiliated Hospital of Anhui Medical University